Status:
COMPLETED
Effect of Ondansetron on Spinal-induced Hypotension for Percutaneous Nephrolithotomy
Lead Sponsor:
Mansoura University
Conditions:
Percutaneous Nephrolithotomy
Eligibility:
All Genders
25-60 years
Phase:
EARLY_PHASE1
Brief Summary
Percutaneous nephrolithotomy (PCNL) is the surgical standard for treating large or complex renal stones. The stones are removed by passing a small telescope through the side of the patient directly in...
Detailed Description
This study aims to assess the effect of Ondansetron on spinal induced hypotension when bupivacaine and dexmedetomidine are used intrathecally during spinal anesthesia for percutaneous nephrolithotomy....
Eligibility Criteria
Inclusion
- Patients scheduled for PCNL surgery.
- ASA classification I or II
Exclusion
- Patient refusal
- Contraindication to spinal anesthesia.
- Known allergy to Ondansetron.
- Uncontrolled hypertensive patient.
- Ischemic heart diseases.
- Moderate to severe stenotic valve lesion.
- Atrial fibrillation.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04891484
Start Date
April 1 2021
End Date
September 1 2022
Last Update
September 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and nephrology center
Al Mansurah, Dakahlia Governorate, Egypt, 050